docturnal

company

About

Docturnal is an online platform that enables individuals to find information and diagnostic services related to diabetes, cancer, and more.

  • 1 - 10

Details

Last Funding Type
Seed
Industries
Biotechnology,Diabetes,Health Care,Health Diagnostics
Founded date
Apr 1, 2016
Number Of Employee
1 - 10
Operating Status
Active

Docturnal offers custom content for diabetes, heart, cancer, Autism, and Arthritis for users who have a condition or their concerned ones.

The company is a point of care screening and diagnostics provider of non-invasive and proactive detection of diseases. Docturnal’s product portfolio also includes solutions for CoPD and Asthma with a pipeline of lung based ailments that can be identified by an aural component. Docturnal products are designed to make detection of diseases easy and hassle-free. Essentially it means being accessible and affordable to the last mile.

Docturnal was established in April 2016.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
docturnal has raised a total of — in funding over 2 rounds. Their latest funding was raised on Aug 3, 2017 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 3, 2017 Seed 1 AIRmaker Detail

Investors

Number of Lead Investors
Number of Investors
1
1
docturnal is funded by 1 investors. AIRmaker are the most recent investors.
Investor Name Lead Investor Funding Round
AIRmaker Yes Seed